Jan 4, 2023
By Tom Avril | The Philadelphia Inquirer The FDA may approve a new drug for Alzheimer’s as soon as this week. But policy experts warn that the health care system is ill-equipped to identify which patients might be eligible for the drug, called lecanemab, as the...
Jan 4, 2023
By Carmen Leitch, Short-epitope Mapping | LabRoots Right now, there are no blood tests that can reliably diagnose Alzheimer’s disease on their own. Most people only get diagnosed with the neurodegenerative disorder after symptoms like memory loss arise, or...
Jan 3, 2023
Anastasia Gorelova-Pittsburgh | Futurity A new test detects a novel marker of Alzheimer’s disease neurodegeneration in a blood sample, researchers report. The biomarker, called “brain-derived tau,” or BD-tau, outperforms current blood diagnostic tests used to detect...
